Showing results (111-120 of 133) with videos related to

Sort By:
Pageof 14
International Journal of Surgical Pathology|November 19, 2025
Desmoplastic Myxoid Tumor of the Pineal Region, <i>SMARCB1</i>-Mutant: Report of 2 Examples of an Extremely Rare EntityAditi Goyal, Preeti Chawla, R T Rajeswarie, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 4, 2018
Defects in synaptic transmission at the neuromuscular junction precede motor deficits in a TDP-43<sup>Q331K</sup> transgenic mouse model of amyotrophic lateral sclerosisKirat K Chand, Kah Meng Lee, John D Lee, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|May 14, 2020
Complicated Alcohol Withdrawal-An Unintended Consequence of COVID-19 LockdownVenkata Lakshmi Narasimha, Lekhansh Shukla, Diptadhi Mukherjee, et al.
Transboundary and Emerging Diseases|December 14, 2011
Isolation of bluetongue virus serotype 1 from Culicoides vector captured in livestock farms and sequence analysis of the viral genome segment-2A I Dadawala, S K Biswas, W Rehman, et al.
Plos One|September 12, 2013
Dynamics of forest malaria transmission in Balaghat district, Madhya Pradesh, IndiaNeeru Singh, Sunil K Chand, Praveen K Bharti, et al.
Scientific Reports|July 9, 2016
Tick holocyclotoxins trigger host paralysis by presynaptic inhibitionKirat K Chand, Kah Meng Lee, Nickolas A Lavidis, et al.
NPJ Regenerative Medicine|November 19, 2021
Combination of human endothelial colony-forming cells and mesenchymal stromal cells exert neuroprotective effects in the growth-restricted newbornKirat K Chand, Jatin Patel, S T Bjorkman, et al.
Lung Cancer (Amsterdam, Netherlands)|February 16, 2015
Phase II study of afatinib, an irreversible ErbB family blocker, in demographically and genotypically defined lung adenocarcinomaJacques De Grève, Teresa Moran, Marie-Pascale Graas, et al.
The Indian Journal of Medical Research|July 4, 2015
Socio-economic & household risk factors of malaria in tribal areas of Madhya Pradesh, central IndiaRavendra K Sharma, Mrigendra P Singh, Kalyan B Saha, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
Continued use of afatinib with the addition of cetuximab after progression on afatinib in patients with EGFR mutation-positive non-small-cell lung cancer and acquired resistance to gefitinib or erlotinibLeora Horn, Scott Gettinger, D Ross Camidge, et al.
Pageof 14